A new survey has revealed that a staggering 94 per cent of healthcare professionals doubt the NHS can provide safe, ongoing ...

Most policies still exclude weight-loss medications under general exclusions unless they are part of the treatment of a ...

Many US employers plan to pare health benefits as weight-loss spending soars - Nation and World News | Hawaii Tribune-Herald ...

After interviewing dozens of people on weight loss drugs like Zepbound and Ozempic, my view of GLP-1s has completely changed ...

The findings from the Kinsey Institute and DatingAdvice come as 6.7 million Americans have been reported as using GLP-1 medications ...

One year ago, we recommended buying ResMed stock after concerns that weight loss drugs would hurt demand for its sleep apnea ...

Among employers with 500 or more workers, 51% said they planned to increase cost-sharing in 2026, including raising deductibles and maximum out-of-pocket costs for workers ...

GLP-1s double as not only a weight loss drug but also a dating confidence booster. Fifty-nine percent of surveyed GLP-1 users ...

According to a new report from Big Chalk Analytics, GLP-1 users have cut $6.5 billion from U.S. grocery spend.

Individualized ocular characteristics should be considered before starting GLP-1 RA therapies for weight loss and diabetes management.

The intense demand for GLP-1 agonists stems from their proven efficacy in managing type 2 diabetes and, increasingly, in facilitating significant weight loss. However, patients often face substantial ...